Lesson plan
Donitriptan
Donitriptan ( ; developmental code name F-11356) is a triptan drug which was investigated as an antimigraine agent but was never marketed. It acts as a selective serotonin 5-HT 1B and 5-HT 1D receptor agonist. The drug reached phase 2 clinical trials prior to the discontinuation of its development.
Article summary
Donitriptan ( ; developmental code name F-11356) is a triptan drug which was investigated as an antimigraine agent but was never marketed. It acts as a selective serotonin 5-HT 1B and 5-HT 1D receptor agonist. The drug reached phase 2 clinical trials prior to the discontinuation of its development.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.